[1] Kearney PM, Whelton M, Reynolds K, et al.Global burden of hypertension: analysis of worldwide data[J]. Lancet,2005,365(9455):217-223.
[2] McAdam-Marx C, Ye X, Sung JC, et al. Results of a retrospective, observational pilot study using electronic medical records to assess the prevalence and characteristics of patients with resistant hypertension in an ambulatory care setting[J]. Clin Ther,2009,31(5):1116-1123.
[3] Krum H, Schlaich M, Whitbourn R, et al.Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study[J]. Lancet,2009,373(9671):1275-1281.
[4] Krum H, Schlaich MP, Sobotka PA, et al.Percutaneous renal denervation in patients with treatment-resistant hypertension: final 3-year report of the Symplicity HTN-1 study[J]. Lancet,2014,383(9917):622-629.
[5] Esler MD, Krum H, Schlaich M, et al.Renal sympathetic denervation for treatment of drug-resistant hypertension: one-year results from the Symplicity HTN-2 randomized, controlled trial[J]. Circulation,2012,126(25):2976-2982.
[6] Esler MD, Böhm M, Sievert H, et al.Catheter-based renal denervation for treatment of patients with treatment-resistant hypertension: 36 month results from the SYMPLICITY HTN-2 randomized clinical trial[J]. Eur Heart J,2014,35(26):1752-1759.
[7] Bhatt DL, Kandzari DE, O'Neill WW, et al. A controlled trial of renal denervation for resistant hypertension[J]. N Engl J Med,2014,370(15):1393-1401.
[8] 蒋雄京, 高润霖. SIMPLICITY HTN 3研究后时代:去肾神经术治疗难治性高血压的现状与挑战[J]. 中华医学杂志,2014,94(23):1761-1763.
[9] Persu A, Jin Y, Fadl Elmula FE, et al.Renal denervation after Symplicity HTN-3: an update[J]. Curr Hypertens Rep,2014,16(8):460.
[10] 蒋雄京, 董徽. SYMPLICITY HTN-3结果阴性不能否定经导管肾神经消融理念[J]. 中国循环杂志,2014,29(6):404-405.
[11] Esler M.Illusions of truths in the Symplicity HTN-3 trial: generic design strengths but neuroscience failings[J]. J Am Soc Hypertens,2014,8(8):593-598.
[12] Böhm M, Mahfoud F, Ukena C, et al.First report of the Global SYMPLICITY Registry on the effect of renal artery denervation in patients with uncontrolled hypertension[J]. Hypertension,2015,65(4):766-774.
[13] Townsend RR, Mahfoud F, Kandzari DE, et al.Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trial[J]. Lancet,2017,390(10108):2160-2170.
[14] 董徽, 蒋雄京. 去肾神经仍是治疗难治性高血压有希望的方法[J]. 中华高血压杂志,2014,22(11):1018-1020.
[15] 蒋雄京, 熊洪亮. 去肾交感神经术治疗高血压的再思考与阜外经验[J]. 心脑血管病防治,2016,16(5):329-332.
[16] Fengler K, Ewen S, Höllriegel R, et al.Blood pressure response to main renal artery and combined main renal artery plus branch renal denervation in patients with resistant hypertension[J]. J Am Heart Assoc,2017,6(8):e006196.
